Logo image of VCKA

VICKERS VANTAGE CORP I (VCKA) Stock Fundamental Analysis

NASDAQ:VCKA - Nasdaq - KYG9440B1077 - Common Stock - Currency: USD

9.01  -0.99 (-9.9%)

After market: 10.16 +1.15 (+12.76%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VCKA. VCKA was compared to 0 industry peers in the Unkown industry. While VCKA seems to be doing ok healthwise, there are quite some concerns on its profitability. VCKA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VCKA was profitable.
VCKA had a negative operating cash flow in the past year.
VCKA Yearly Net Income VS EBIT VS OCF VS FCFVCKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 500K -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA 0.31%
ROE 0.5%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VCKA Yearly ROA, ROE, ROICVCKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VCKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VCKA Yearly Profit, Operating, Gross MarginsVCKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for VCKA remains at a similar level compared to 1 year ago.
VCKA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VCKA Yearly Shares OutstandingVCKA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 5M 10M 15M
VCKA Yearly Total Debt VS Total AssetsVCKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that VCKA is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for VCKA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACCN/A
WACCN/A
VCKA Yearly LT Debt VS Equity VS FCFVCKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.02 indicates that VCKA should not have too much problems paying its short term obligations.
A Quick Ratio of 1.02 indicates that VCKA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
VCKA Yearly Current Assets VS Current LiabilitesVCKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 100K 200K 300K 400K 500K

More info and screens

0

3. Growth

3.1 Past

VCKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.28%.
EPS 1Y (TTM)-15.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%974.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 180.20, which means the current valuation is very expensive for VCKA.
Compared to an average S&P500 Price/Earnings ratio of 26.35, VCKA is valued quite expensively.
Industry RankSector Rank
PE 180.2
Fwd PE N/A
VCKA Price Earnings VS Forward Price EarningsVCKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VCKA Per share dataVCKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VCKA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VICKERS VANTAGE CORP I

NASDAQ:VCKA (11/10/2022, 7:19:45 PM)

After market: 10.16 +1.15 (+12.76%)

9.01

-0.99 (-9.9%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)11-25 2022-11-25/bmo
Inst Owners1.96%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap118.72M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 180.2
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.05
EY0.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0
BVpS6.79
TBVpS6.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.31%
ROE 0.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 1.19
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%974.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-606.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A